Putting Big Pharma first and America last, the Biden administration moves to cancel Trump-era price reductions on life-saving medical treatments.
The White House last week reportedly approved Biden’s request to rescind Trump’s executive order to force Big Pharma to lower prices for insulin and EpiPens, according to Fox Business.
The Biden administration has not yet officially announced the retraction, but it could be published by the Department of Health and Human Services this week, the outlet said.
Biden’s approved bid to cancel the previous administration’s healthcare policy comes after Biden issued a “Regulatory Freeze Pending Review” on the order upon assuming office on Jan. 20.
One of Biden’s first actions in office was to end discounts on life-saving medical treatments. It’s disturbing to say the least that this was his top priority.
The “review” temporarily delayed the implementation of Trump’s order for 60 days from its effective date which was Jan. 22 – before it was completely retracted last week.
Trump’s executive order signed on Dec. 23, 2020 stated “it is the policy of the United States to enable Americans without access to affordable insulin and injectable epinephrine through commercial insurance or federal programs, such as Medicare and Medicaid, to purchase these pharmaceuticals from a health center at the same price at which the health center acquired the medication through the 340B Program.”
Now, under Biden, low-income Americans will not have access to affordable insulin and EpiPens.
From day one, Biden intended to undo most of Trump’s accomplishments, but I had hope that the one he might keep is this one which would have benefitted people who depend on these treatments to survive.
It’s hard to imagine that any president, elected to represent the people, would rescind an order that provides such significant life-saving benefits to Americans as Trump’s Big Pharma measure would have.
Unfortunately, Biden has proven again that he does not represent the people, nor does he try to pretend like he does. Instead, he handed over those in need of insulin and EpiPens to billion-dollar Big Pharma industries to continue taking advantage of their medical necessities.